Management of glycemia in type 2 diabetes

Clinical Cornerstone

Volumn 1, Issue 3, 1998, Pages 39-57

  Buse, John B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; INSULIN;

BLOOD; BLOOD GLUCOSE MONITORING; DIABETIC DIET; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; METABOLISM; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY HEALTH CARE; REVIEW; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIFE STYLE; PRIMARY HEALTH CARE; TREATMENT OUTCOME;

EID: 0032222508     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1098-3597(98)90017-5     Document Type: Article

References (21)

1. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853.
2. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865.
3. Buse JB, Hroscikoski M. The case for a role for postprandial glucose monitoring in diabetes management. J Fam Pract. 1998;47(suppl):S29-S36.
4. Clinical practice recommendations. American Diabetes Association. Diabetes Care. 1998;21(suppl 1):S1-S94. Available in full text at: http://www.diabetes.org/DiabetesCare/Supplementl98/default.htm.
5. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of the long-term complications of insulin-dependent diabetes mellitus. NEJM. 1993;329:977-986.
6. Herman WH, Dasbach EJ, Songer TJ, Eastman RC. The cost-effectiveness of intensive therapy for diabetes mellitus. Endocrinol Metab Clin North Am. 1997;26:679-696.
7. Roman SH, Harris MI. Management of diabetes from a public health perspective. Endocrinol Metab Clin North Am. 1997;26:443-474.
8. Franz MJ. Lifestyle modification for diabetes management. Endocrinol Metab Clin North Am. 1997;26: 499-510.
9. Levine GN, Balady GJ. The benefits and risks of exercise training: the exercise prescription. Adv Intern Med. 1993;38:57-79.
10. Abraira C, Colwell JA, Nuttall FQ, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VACSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care. 1995;18:1113-1123.
11. Bell PM, Hadden DR. Metformin. Endocrinol Metab Clin North Am. 1997;26:523-538.
12. Burge MR, Schade DS. Insulins. Endocrinol Metab Clin North Am. 1997;26:575-598.
13. Henry RR. Thiazolidinediones. Endocrinol Metab Clin North Am. 1997;26:5553-5574.
14. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995;18(2):258-268.
15. Lebovitz HE. Alpha-glucosidase inhibitors. Endocrinol Metab Clin North Am. 1997;26:539-552.
16. Malmberg K. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ. 1997; 314:1512-1515.
17. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103-117.
18. Riddle MC. Tactics for type 2 diabetes. Endocrinol Metab Clin North Am. 1997;26:659-678.
19. Zimmerman BR. Sulfonylureas. Endocrinol Metab Clin North Am. 1997;26:511-522.
20. de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose-monitoring in women with gestational diabetes mellitus requiring insulin therapy. NEJM. 1995;333:1237-1241.
21. Hirsch IB, Paauw DS. Diabetes management in special situations. Endocrinol Metab Clin North Am. 1997; 26:631-646.